G. Lemesle

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Serum MMP-8: A Novel Indicator of Left Ventricular Remodeling and Cardiac Outcome in Patients after Acute Myocardial Infarction

P. Amouyel, A. Turkieh, M. Fertin, 2013, PloS one.

Stent length as a potential indicator to select patients who may benefit from long- term dual antiplatelet therapy

G. Lemesle, G. Schurtz, A. Manchuelle, 2015 .

Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study).

G. Lemesle, N. Lamblin, C. Bauters, 2014, American heart journal.

Rate of nuisance bleedings and impact on compliance to prasugrel in acute coronary syndromes.

G. Lemesle, L. Jacquin, M. Pansieri, 2011, The American journal of cardiology.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.

E. Vicaut, I. Durand-zaleski, G. Lemesle, 2021, JAMA.

Relationship between post‐treatment platelet reactivity and ischemic and bleeding events at 1‐year follow‐up in patients receiving prasugrel

G. Lemesle, M. Pansieri, L. Maillard, 2012, Journal of thrombosis and haemostasis : JTH.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Letter by Bonello et al Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".

G. Lemesle, L. Bonello, M. Laine, 2019, Circulation.

Should we screen for masked hypertension in patient with vascular disease?

G. Lemesle, C. Delhaye, C. Mounier‐Véhier, 2010, Vascular health and risk management.

Compared Impact of Diabetes on the Risk of Heart Failure from Acute Myocardial Infarction to Chronic Coronary Artery Disease.

L. Fauchier, J. Ferrières, G. Lemesle, 2021, Diabetes & metabolism.

Clopidogrel Use as Single Antiplatelet Therapy in Outpatients with Stable Coronary Artery Disease: Prevalence, Correlates and Association with Prognosis (from the CORONOR Study)

G. Lemesle, N. Lamblin, C. Bauters, 2016, Cardiology.

Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.

G. Lemesle, N. Lamblin, C. Bauters, 2017, Journal of the American College of Cardiology.

Secondary medical prevention and clinical outcome in coronary artery disease patients with a history of non-coronary vascular intervention: A report from the CORONOR investigators

S. Haulon, G. Lemesle, N. Lamblin, 2015, European journal of preventive cardiology.

Thrombus aspiration for the treatment of definite stent thrombosis.

G. Lemesle, C. Delhaye, J. Lablanche, 2010, Archives of cardiovascular diseases.

High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis

G. Lemesle, C. Bauters, T. Gourlay, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis.

G. Lemesle, N. Lamblin, P. De Groote, 2018, Journal of cardiac failure.

Prognostic impact of ß-blocker use in patients with stable coronary artery disease

G. Lemesle, N. Lamblin, P. De Groote, 2014, Heart.

Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study).

G. Lemesle, N. Lamblin, C. Bauters, 2017, Journal of cardiology.

Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015.

J. Ferrières, G. Lemesle, N. Danchin, 2019, American heart journal.

Temporal trends in clinical characteristics and management according to sex in patients with cardiogenic shock after acute myocardial infarction: The FAST-MI programme.

J. Ferrières, G. Lemesle, N. Danchin, 2018, Archives of cardiovascular diseases.

Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015

J. Ferrières, G. Lemesle, P. Steg, 2017, Circulation.

The Presence of Apoptotic Bone Marrow Cells Impairs the Efficacy of Cardiac Cell Therapy

R. Neviere, G. Lemesle, F. Mouquet, 2011, Cell transplantation.

Early versus delayed invasive strategy for intermediate‐ and high‐risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial

K. Baumstarck, G. Lemesle, Z. Boueri, 2018, Clinical cardiology.

Bivalirudin during percutaneous coronary intervention in acute coronary syndromes

G. Lemesle, L. Bonello, M. Laine, 2018, Expert opinion on pharmacotherapy.

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

G. Lemesle, C. Bauters, E. Puymirat, 2015, Archives of cardiovascular diseases.

High on‐treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta‐analysis

G. Lemesle, C. Bauters, M. Hamon, 2015, Journal of thrombosis and haemostasis : JTH.

Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries.

J. Jukema, T. Lüscher, P. Erne, 2016, European heart journal. Cardiovascular pharmacotherapy.

Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program.

J. Ferrières, G. Lemesle, N. Danchin, 2020, Journal of clinical lipidology.

Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper

M. Banach, M. Bernardi, G. Lemesle, 2022, Archives of medical science : AMS.

Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).

J. Ferrières, G. Lemesle, N. Danchin, 2012, JACC. Cardiovascular interventions.

Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation.

L. Fauchier, É. Marijon, G. Lemesle, 2021, International journal of cardiology.

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.

G. Lemesle, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

G. Lemesle, M. Alessi, T. Cuisset, 2020, Thrombosis and Haemostasis.

Utility and safety of coronary angiography in patients with acute infective endocarditis who required surgery.

G. Lemesle, C. Bauters, L. Bonello, 2020, The Journal of thoracic and cardiovascular surgery.

Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.

M. Remy-Jardin, M. Fertin, G. Lemesle, 2018, Archives of cardiovascular diseases.

Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease

G. Lemesle, D. Sibbing, E. Puymirat, 2018, Thrombosis and Haemostasis.

Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized Trial.

K. Baumstarck, G. Lemesle, Z. Boueri, 2020, JACC. Cardiovascular interventions.

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

A giant right coronary artery related to a small fistula to the coronary sinus.

G. Lemesle, P. Degroote, M. Richardson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

The clinical significance of hematocrit values before and after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

It's never too early to beat your low-density lipoprotein cholesterol.

N. Mewton, F. Mach, G. Lemesle, 2021, Archives of cardiovascular diseases.

Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions.

G. Lemesle, N. Lamblin, C. Bauters, 2015, Archives of cardiovascular diseases.

Relative Importance of Heart Failure Events Compared to Stroke and Bleeding in AF Patients

G. Lemesle, N. Lamblin, C. Bauters, 2021, Journal of clinical medicine.

Impact of initial clinical presentation on clopidogrel low response.

G. Lemesle, C. Bauters, S. Susen, 2013, Archives of cardiovascular diseases.

Response to Letters Regarding Article, “Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?”

G. Lemesle, K. Kent, A. Pichard, 2011 .

Genotypic and Phenotypic Assessment of Platelet Function and Response to P2Y12 Antagonists

G. Lemesle, L. Bonello, J. Doazan, 2011, Current cardiology reports.

Personalized antiplatelet therapy for coronary artery disease patients: is this the future?

G. Lemesle, P. Barragan, L. Bonello, 2009, Expert review of cardiovascular therapy.

Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors.

G. Lemesle, K. Kent, A. Pichard, 2010, European heart journal.

Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap

G. Lemesle, N. Lamblin, C. Bauters, 2020, Open Heart.

Outcomes in patients with intra-aortic balloon pump who met the same inclusion criteria in the PROTECT II (a prospective feasibility trial investigating the use of the impella recover LP 2.5 system in patients undergoing high risk percutaneous coronary intervention) Study

G. Lemesle, K. Kent, A. Pichard, 2009 .

Dosing Strategies for Antiplatelet Therapy in Percutaneous Coronary Intervention

G. Lemesle, C. Bauters, C. Delhaye, 2010, Hospital practice.

Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention.

G. Lemesle, P. Barragan, L. Bonello, 2010, Thrombosis research.

Emergence of the concept of platelet reactivity monitoring of response to thienopyridines

G. Lemesle, A. Pichard, P. Barragan, 2009, Heart.

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?

G. Lemesle, K. Kent, A. Pichard, 2010, Cardiovascular revascularization medicine : including molecular interventions.

P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries.

J. Jukema, T. Lüscher, P. Erne, 2016, European heart journal. Cardiovascular pharmacotherapy.

Dual antiplatelet therapy and non-cardiovascular mortality

G. Lemesle, 2015, The Lancet.

Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.

G. Lemesle, N. Lamblin, C. Bauters, 2015, Archives of cardiovascular diseases.

Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry

J. Ferrières, G. Lemesle, P. Steg, 2017, European heart journal. Acute cardiovascular care.

Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up

G. Lemesle, E. Puymirat, L. Bonello, 2019, Cardiology research and practice.

Axillary/subclavian access for transcather aortic valve replacement

G. Lemesle, T. Modine, A. Sudre, 2013 .

Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes.

G. Lemesle, C. Delhaye, T. Modine, 2012, The Annals of thoracic surgery.

Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Aspirin on Top of Anticoagulation in Patients With Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet

G. Lemesle, 2019, Circulation.

Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study

G. Lemesle, S. Porouchani, G. Bonnet, 2021, The Lancet Regional Health - Europe.

Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis

J. Granada, G. Lemesle, N. Lamblin, 2022, Heart.

Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention.

G. Lemesle, L. Bonello, M. Laine, 2016, International journal of cardiology.

Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study.

R. Guieu, G. Lemesle, L. Arnaud, 2015, International journal of cardiology.

Clinical significance of myocardial work parameters after acute myocardial infarction

J. Granada, G. Lemesle, N. Lamblin, 2022, European heart journal open.

Physiological Evaluation of Anomalous Aortic Origin of a Coronary Artery Using Computed Tomography–Derived Fractional Flow Reserve

M. Togni, G. Lemesle, P. Rougier, 2021, Journal of the American Heart Association.

Haemodynamic support during high-risk percutaneous coronary intervention.

G. Lemesle, L. Bonello, M. Laine, 2022, Archives of cardiovascular diseases.

Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study

G. Lemesle, G. Vanzetto, A. Rousseau, 2020, The Lancet Public Health.

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome

P. Morange, R. Guieu, G. Lemesle, 2019, Platelets.

Hemodynamic Profiles of Cardiogenic Shock Depending on Their Etiology

G. Lemesle, E. Puymirat, L. Bonello, 2020, Journal of clinical medicine.

Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab

G. Lemesle, F. Juthier, D. Launay, 2021, Cardiac failure review.

Research and Therapeutic Nihilisms in Chronic Kidney Disease.

G. Lemesle, E. Puymirat, L. Bonello, 2017, JACC: Cardiovascular Interventions.

CORONARY ARTERY DISEASE Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

G. Lemesle, K. Kent, A. Pichard, 2009 .

Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.

J. Ferrières, G. Lemesle, N. Danchin, 2020, European heart journal.

Delivery catheter cone separation and embolization after Corevalve dislocation by subclavian approach.

G. Lemesle, C. Delhaye, T. Modine, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.

G. Chatellier, I. Durand-zaleski, G. Lemesle, 2021, The New England journal of medicine.

Poor agreement between light transmission aggregometry, Verify Now P2Y12 and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: A potential explanation of negative results of recent randomized trials

G. Lemesle, C. Bauters, S. Susen, 2014, Platelets.

HOW TO MANAGE PATIENTS WITH LOW RESPONSE TO CLOPIDOGREL Clopidogrel dosage The Intracoronary Stenting and Antithrombotic Regimen : Choose Between 3 High Oral Doses

G. Lemesle, A. Pichard, P. Barragan, 2009 .

Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2008, American Journal of Cardiology.

Long-Term Clinical Outcomes According to Previous Manifestations of Atherosclerotic Disease (from the FAST-MI 2010 Registry).

J. Ferrières, G. Lemesle, N. Danchin, 2017, The American journal of cardiology.

Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: first case report.

G. Lemesle, T. Modine, A. Sudre, 2010, The Journal of thoracic and cardiovascular surgery.

Incidence and predictors of microvascular dysfunction assessed by the index of microcirculatory resistance following primary PCI for ST-elevation myocardial infarction.

G. Lemesle, L. Bonello, F. Paganelli, 2011, International journal of cardiology.

Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters.

G. Lemesle, N. Lamblin, S. Porouchani, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Very late stent thrombosis after bare-metal stent implantation: case reports and review of the literature.

G. Lemesle, R. Waksman, T. P. Pinto Slottow, 2009, The Journal of invasive cardiology.

Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study

G. Lemesle, G. Vanzetto, A. Rousseau, 2020, The Lancet Public Health.

Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention.

G. Luc, G. Lemesle, C. Bauters, 2013, International journal of cardiology.

Vitamin K antagonists with or without long‐term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events

Deepak L. Bhatt, C. Cannon, G. Lemesle, 2017, Clinical cardiology.

Impact of the adjunction of aspirin on top of oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation.

G. Lemesle, N. Lamblin, C. Bauters, 2016 .

Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation.

G. Lemesle, N. Lamblin, C. Bauters, 2016, Panminerva medica.

Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction

M. Krempf, J. Ferrières, G. Lemesle, 2020, European heart journal. Acute cardiovascular care.

Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact.

G. Lemesle, N. Lamblin, C. Bauters, 2017, Archives of cardiovascular diseases.

Incidence and determinants of cerebrovascular events in outpatients with stable coronary artery disease

G. Lemesle, N. Lamblin, C. Bauters, 2018, European stroke journal.

Paclitaxel‐eluting balloon: From bench to bed

G. Lemesle, M. Scheinowitz, R. Pakala, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.

Pascal Leprince, Christoph Nix, Cristian Preda, 2018, Journal of the American College of Cardiology.

Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.

G. Lemesle, C. Bauters, C. Delhaye, 2010, Archives of cardiovascular diseases.

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

G. Lemesle, C. Delhaye, G. Schurtz, 2014, Medical devices.

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.

G. Lemesle, K. Kent, A. Pichard, 2009, Archives of cardiovascular diseases.

Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care

G. Lemesle, N. Lamblin, P. Henry, 2020, CJC Open.

Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Drug-eluting stents: issues of late stent thrombosis.

G. Lemesle, S. Collins, R. Waksman, 2010, Cardiology clinics.

Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents.

G. Lemesle, A. Pichard, L. Satler, 2009, Journal of interventional cardiology.

Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.

G. Lemesle, A. Pichard, R. Waksman, 2009, Archives of cardiovascular diseases.

Stent thrombosis in 2008: definition, predictors, prognosis and treatment.

G. Lemesle, R. Waksman, C. Delhaye, 2008, Archives of cardiovascular diseases.

Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes

J. Jukema, T. Lüscher, P. Erne, 2017, European heart journal. Cardiovascular pharmacotherapy.

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.

G. Stone, A. Kirtane, F. Gaita, 2013, International journal of cardiology.

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

G. Lemesle, C. Bauters, C. Delhaye, 2009, Cardiovascular revascularization medicine : including molecular interventions.

Very long-term outcomes of older adults with stable coronary artery disease (from the CORONOR study)

G. Lemesle, N. Lamblin, C. Bauters, 2021, Coronary artery disease.

Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.

G. Lemesle, C. Bauters, C. Delhaye, 2009, American heart journal.

Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction.

G. Lemesle, N. Lamblin, P. De Groote, 2016, International journal of cardiology.

Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trials

G. Lemesle, C. Bauters, 2016, BMC Cardiovascular Disorders.

Multimarker Proteomic Profiling for the Prediction of Cardiovascular Mortality in Patients with Chronic Heart Failure

P. Amouyel, G. Lemesle, N. Lamblin, 2015, PloS one.

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

G. Lemesle, K. Kent, A. Pichard, 2010, Circulation.

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis.

L. Boyer, G. Lemesle, E. Puymirat, 2016, JACC. Cardiovascular interventions.

Apolipoprotein Proteomic Profiling for the Prediction of Cardiovascular Death in Patients with Heart Failure

P. Amouyel, V. Chouraki, A. Turkieh, 2020, Proteomics. Clinical applications.

Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial

E. Vicaut, I. Durand-zaleski, G. Lemesle, 2021, Clinical cardiology.

Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients.

G. Lemesle, N. Lamblin, P. De Groote, 2017, Archives of cardiovascular diseases.

, Failure Circulating Long Noncoding RNA , LIPCAR , Predicts Survival in Patients With Heart

G. Lemesle, C. Bauters, F. Pinet, 2022 .

Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association between rs4149056 variant in SLCO1B1 and early discontinuation of statin after acute myocardial infarction.

J. Ferrières, G. Lemesle, N. Danchin, 2020, Pharmacogenomics.

Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence, Determinants, and Outcome (From the CORONOR Study).

G. Lemesle, N. Lamblin, C. Bauters, 2018, JACC. Cardiovascular interventions.

Simple risk models to predict cardiovascular death in patients with stable coronary artery disease

J. Tardif, R. Ferrari, G. Lemesle, 2020, European heart journal. Quality of care & clinical outcomes.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial.

G. Lemesle, G. Rangé, G. Cayla, 2020, American heart journal.

Perioperative outcomes in reoperative cardiac surgery guided by cardiac multidetector computed tomographic angiography.

Allen J. Taylor, G. Lemesle, A. Pichard, 2010, American heart journal.

Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.

G. Lemesle, C. Bauters, C. Delhaye, 2010, Cardiovascular revascularization medicine : including molecular interventions.

Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease.

G. Lemesle, N. Lamblin, C. Bauters, 2014, Journal of the American College of Cardiology.

Platelet reactivity in diabetic patients subjected to acute exercise stress test.

G. Lemesle, A. Pichard, M. Scheinowitz, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Elective Coronary Revascularization Procedures in Patients With StableCoronary Artery Disease

G. Lemesle, N. Lamblin, C. Bauters, 2018 .

Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations.

J. López-Sendón, J. Jukema, T. Lüscher, 2015, European heart journal. Cardiovascular pharmacotherapy.

A Critical Appraisal of the Safety and Efficacy of Drug‐Eluting Stents

G. Lemesle, R. Waksman, G. Maluenda, 2009, Clinical pharmacology and therapeutics.

Gender differences in clinical characteristics, medical management, risk factor control, and long-term outcome of patients with stable coronary artery disease: from the CORONOR registry.

G. Lemesle, N. Lamblin, C. Bauters, 2020, Panminerva medica.

Acute coronary syndromes Contemporary registries on P 2 Y 12 inhibitors in patients with acute coronary syndromes in Europe : overview and methodological considerations

J. López-Sendón, J. Jukema, T. Lüscher, 2015 .

Biolimus-eluting stent with biodegradable polymer (Nobori®): an overview of recent clinical results, SORT OUT V and COMPARE II trials

G. Lemesle, C. Delhaye, G. Schurtz, 2013, Expert review of cardiovascular therapy.

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French Cardiologists

G. Lemesle, N. Lamblin, C. Bauters, 2015, EBioMedicine.

Impact of Pre-Existing History of Heart Failure on Patient Profile, Therapeutic Management, and Prognosis in Cardiogenic Shock: Insights from the FRENSHOCK Registry

B. Harbaoui, G. Lemesle, N. Lamblin, 2022, Life.

Incidence, Source, and Prognostic Impact of Major Bleeding Across the Spectrum of Aortic Stenosis.

G. Lemesle, N. Lamblin, C. Bauters, 2023, American heart journal.

Vascular brachytherapy for patients with drug-eluting stent restenosis.

G. Lemesle, A. Pichard, L. Satler, 2008, Journal of interventional cardiology.

Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?" (Cardiovasc Revasc Med 2010;11(2):91–7)

G. Lemesle, K. Kent, A. Pichard, 2011 .

Feasibility and safety of transfemoral transcatheter aortic valve implantation performed with a percutaneous coronary intervention-like approach.

G. Lemesle, N. Lamblin, S. Porouchani, 2021, Archives of cardiovascular diseases.

IMPELLA® or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock

G. Lemesle, N. Lamblin, S. Porouchani, 2021, Journal of clinical medicine.

One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial.

E. Vicaut, G. Lemesle, P. Steg, 2022, Circulation.

Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease

G. Lemesle, N. Lamblin, C. Bauters, 2020, Journal of clinical medicine.

Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry

G. Lemesle, N. Lamblin, P. De Groote, 2020, ESC heart failure.

Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation: A Review of the Current Guidelines and Literature

G. Lemesle, C. Delhaye, L. Bonello, 2011, Hospital practice.

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

G. Lemesle, C. Bauters, E. Puymirat, 2015, Archives of cardiovascular diseases.

Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

High on‐treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta‐analysis

G. Lemesle, C. Bauters, M. Hamon, 2015, Journal of thrombosis and haemostasis : JTH.

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

G. Lemesle, C. Bauters, E. Puymirat, 2015, Archives of Cardiovascular Diseases.

Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure

G. Lemesle, P. De Groote, C. Bauters, 2014, Circulation research.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Incidence and predictors of mortality after an electrical storm in the ICU.

G. Lemesle, N. Lamblin, D. Lacroix, 2022, European heart journal. Acute cardiovascular care.

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion

N. Mewton, G. Lemesle, E. Puymirat, 2023, Frontiers in cardiovascular medicine.

OCT Analysis of Very Early Strut Coverage of the Synergy Stent in Non-ST Segment Elevation Acute Coronary Syndrome Patients.

G. Lemesle, N. Combaret, P. Motreff, 2019, The Journal of invasive cardiology.

Relationship between post‐treatment platelet reactivity and ischemic and bleeding events at 1‐year follow‐up in patients receiving prasugrel

G. Lemesle, L. Bonello, M. Laine, 2012, Journal of thrombosis and haemostasis : JTH.

K. Baumstarck, G. Lemesle, Z. Boueri, 2018, Clinical cardiology.

Very early invasive strategy in patients with non-ST-elevation myocardial infarction: should we go for it?

G. Lemesle, G. Schurtz, Basile Verdier, 2023, Heart.

Thrombus aspiration for the treatment of definite stent thrombosis.

G. Lemesle, C. Delhaye, J. Lablanche, 2010, Archives of cardiovascular diseases.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).

J. Ferrières, G. Lemesle, N. Danchin, 2012, JACC. Cardiovascular interventions.